Abstract
Maltose-binding protein (MBP) produced by Escherichia coli acts as an adjuvant when fused to various antigens. In this study, the antigenic region of hemagglutinin A of Porphyromonas gingivalis with a molecular mass of 25 kDa (25k-hagA) was fused to MBP (25k-hagA-MBP) and the efficacy of the resulting fusion protein as a nasal vaccine was assessed. While nasal immunization with 25k-hagA induced no antibody responses, 25k-hagA-MBP elicited high serum IgG, IgA, and secretory IgA anti-25k-hagA antibodies in the saliva. When 25k-hagA-MBP was co-administered with an established mucosal adjuvant, cholera toxin, 25k-hagA-specific serum IgG and salivary IgA antibody responses were not further elevated. Interestingly, 25k-hagA mixed with MBP failed to induce 25k-hagA-specific antibody responses. These findings suggest that MBP must be fused to the target antigen for induction of antigen-specific antibody responses and that nasal administration of 25k-hagA-MBP may be an effective mucosal vaccine for the prevention of P. gingivalis infection.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.